Arvinas Inc (NASDAQ:ARVN)
| 38.97 Delayed Data As of 4:00pm ET |  -1.37 / -3.40%Today’s Change | 34.90 Today|||52-Week Range 83.40 | -52.56% Year-to-Date |
Latest ARVN News | Press Releases
No recent news for Arvinas Inc.
Today’s Trading
| Previous close | 40.34 |
| Today’s open | 40.12 |
| Day’s range | 37.94 - 40.63 |
| Volume | 31,591 |
| Average volume (3 months) | 432,296 |
| Market cap | $2.1B |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -26.56% |
| Earnings growth (this year) | -29.15% |
| Earnings growth (next 5 years) | -15.46% |
| Revenue growth (last year) | +114.20% |
| P/E ratio | NM |
| Price/Sales | 87.94 |
| Price/Book | 2.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IBRXImmunitybio Inc | -0.31 | -5.81% |
| ---- | ||
| BCRXBioCryst Pharmaceuti... | -0.01 | -0.12% |
| TLRYTilray Brands Inc | -0.20 | -5.06% |
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | -$1.18 |
| Annual revenue (last year) | $46.7M |
| Annual profit (last year) | -$191.0M |
| Net profit margin | -408.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
